The start-up will launch a cycle-synced lifestyle app to help women manage their hormonal health
Endometrial cancer is the most commonly diagnosed gynaecologic cancer in American women
The app has benefitted from a complete redesign and redevelopment to provide clear visual learning for latching
Second novel PCOS drug target from Celmatix-Evotec Alliance progresses into hit-identification
The developers believe the test will help drive the development of new therapeutics for endometriosis
The round brings the company's total funding to US$22.3m, underscoring the need to rebuild US maternity care services
Phexxi will be the first and only hormone-free contraceptive offered by Favor
The clinic has previously raised €17m in funding to expand to Spain, Germany and Italy
As the global femtech market is growing, start-ups turn to the video-sharing platform to upscale their businesses
The cooperative will offer access to fertility care for more than 60 American employers
